Migrén: nyitott vizsgálatok itt: Dél-Korea
2 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
No phaseToborozResearch participation
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
- Where
- Ansan-si, Busan, Changwon-si, Daegu, Daejeon, Gangwon-do, Goyang, Goyang-si, Gwangju, Hwaseong, Hwaseong-si, Iksan, Incheon, Jeonju, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Yongin-si
- Age
- 19 év and over
- People
- 3000
- Run by
- AbbVie
See details and how to joinNCT06603558Regiszter frissítve: 2026-07-22
3. fázisToborozTrial-stage medicine
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Gangseo-gu, Hwaseong-si, Seoul
- Age
- 18 év to 45 év
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466EU 2024-517121-10-00Regiszter frissítve: 2026-07-09
Minden vizsgálat (Migrén) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.